author-photo

Masahiro Sekimizu

Pharmaceuticals and Medical Devices Agency

37

Papers

143

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Tranilast for Advanced Heart Failure in Patients with Muscular Dystrophy: A Single-Arm, Open-Label, Multicenter Study

2021
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan.

2021 Human Pathology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical trial of Childhood, Adolescent and Young Adult Hodgkin Lymphoma in Japan

2020
Show All
- Source
- Cite
- Save
Citations (0)
Association between sites and severity of eczema and the onset of cow's milk and egg allergy in children.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (0)
Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

2020 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (2)
Alectinib for relapsed or refractory ALK‐positive anaplastic large cell lymphoma: an open label phase 2 trial

2020 Cancer Science
Show All
- Source
- Cite
- Save
Citations (10)
Successful blinatumomab retreatment in a patient with BCP-ALL for recurrence after CBT

2019
- Masahiro Sekimizu
Show All
- Source
- Cite
- Save
Citations (0)
Study Protocol for a Multicenter, Open-Label, Single-Arm Study of Tranilast for Cardiomyopathy of Muscular Dystrophy.

2019 The Kurume Medical Journal
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I/II study of crizotinib for recurrent or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma and a phase i study of crizotinib for recurrent or refractory neuroblastoma: Study protocol for a multicenter single-arm open-label trial

2018 Acta Medica Okayama
Show All
- Source
- Cite
- Save
Citations (8)